Lucem Health – a leading provider of transformational clinical AI technology and solutions – announced that it has closed a Series A funding round of $7.7 million. Led by Mayo Clinic, Granger Management and Mercy (St Louis), this funding round builds on Lucem Health’s seed funding and includes financing from existing investor Rally Ventures. The funding round will be used to advance the development of Lucem Health’s platform for clinical AI solution deployment, grow the company’s solution portfolio, and expand its sales and marketing capacity.
Essentially, Lucem Health helps clinical AI innovators transform data science into innovative, trusted solutions that can detect diseases earlier and optimize care delivery, positively impacting patient lives, improving the physician and provider experience, and ultimately producing improved outcomes.
Lucem Health recently launched Lucem Health Reveal, a family of solutions that identify patients who may be at a higher risk of serious or chronic diseases. And Reveal solutions use readily available clinical data to surface previously undiscovered insights, helping physicians and providers deliver improved health outcomes for their patients and greater financial value to their organizations.
KEY QUOTES:
“AI has tremendous potential to transform and augment how physicians and providers practice medicine, make decisions and serve their patients. Yet, so far, we have barely scratched the surface of AI’s potential in healthcare. We started Lucem Health to accelerate integration of powerful AI-generated insights into care delivery workflows in a thoughtful, responsible way. In a challenging market for raising capital, we appreciate our investors’ confidence and support.”
— Sean Cassidy, founding CEO of Lucem Health
